Oncotarget

Vol 3, No 1

January 2012

View Archive »

Order a Reprint

About The Cover

Figure 2 in Chow & Baker outlines a framework for translational research using genetically engineered mouse models (GEMMs) for high-grade astrocytoma (HGA).

Table of Contents

Editorial Comments

Histone code, human growth and cancer

Histone code, human growth and cancer

https://doi.org/10.18632/oncotarget.435

Francesco Crea
1-2
Abstract  |  PDF  |  HTML  |  Order a Reprint

Histone modification defects in developmental disorders and cancer

Histone modification defects in developmental disorders and cancer

https://doi.org/10.18632/oncotarget.436

Nicholas CP Cross
3-4
Abstract  |  PDF  |  HTML  |  Order a Reprint

Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1

Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1

https://doi.org/10.18632/oncotarget.433

Suhwan Chang,  and Shyam K. Sharan
5-6
Abstract  |  PDF  |  HTML  |  Order a Reprint

The Safety of Embryonic Stem Cell Therapy Relies on Teratoma Removal

The Safety of Embryonic Stem Cell Therapy Relies on Teratoma Removal

https://doi.org/10.18632/oncotarget.434

Chad Tang, Irving L. Weissman,  and Micha Drukker
7-8
Abstract  |  PDF  |  HTML  |  Order a Reprint

Reviews

microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers

microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers

https://doi.org/10.18632/oncotarget.424

Nijiro Nohata, Toyoyuki Hanazawa, Hideki Enokida,  and Naohiko Seki
9-21
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Brief Reports

Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells

Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells

https://doi.org/10.18632/oncotarget.437

Max Schlaak, Patrick Schmidt, Christopher Bangard, Peter Kurschat, Cornelia Mauch,  and Hinrich Abken
22-30
Abstract  |  PDF  |  HTML  |  Order a Reprint

Research Papers

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer

https://doi.org/10.18632/oncotarget.430

Roland H. Stauber, Shirley K. Knauer, Negusse Habtemichael, Carolin Bier, Britta Unruhe, Simona Weisheit, Stephanie Spange, Frank Nonnenmacher, Verena Fetz, Torsten Ginter, Sigrid Reichardt, Claus Liebmann, Günter Schneider,  and Oliver H. Krämer
31-43
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma

Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma

https://doi.org/10.18632/oncotarget.417

Hideo Hidaka, Naohiko Seki, Hirofumi Yoshino, Takeshi Yamasaki, Yasutoshi Yamada, Nijiro Nohata, Miki Fuse, Masayuki Nakagawa,  and Hideki Enokida
44-57
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo

“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo

https://doi.org/10.18632/oncotarget.438

Brian A. DeChristopher, Alice C. Fan, Dean W. Felsher,  and Paul A. Wender
58-66
Abstract  |  PDF  |  HTML  |  Order a Reprint

Research Perspectives

Capturing the Molecular and Biological Diversity of High-Grade Astrocytoma in Genetically Engineered Mouse Models

Capturing the Molecular and Biological Diversity of High-Grade Astrocytoma in Genetically Engineered Mouse Models

https://doi.org/10.18632/oncotarget.425

Lionel M.L. Chow,  and Suzanne J. Baker
67-77
Abstract  |  PDF  |  HTML  |  Order a Reprint

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer

https://doi.org/10.18632/oncotarget.332

Helen M. Coley, Eleftheria Hatzmichael, Sarah P. Blagden, Iain A. McNeish, Alastair Thompson, Tim Crook,  and Nelofer Syed
78-83
Abstract  |  PDF  |  HTML  |  Order a Reprint

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics

https://doi.org/10.18632/oncotarget.422

Paul C. McDonald, Jean-Yves Winum, Claudiu T. Supuran,  and Shoukat Dedhar
84-97
Abstract  |  PDF  |  HTML  |  Order a Reprint

Neoplastic cells are a rare component in human glioblastoma microvasculature

Neoplastic cells are a rare component in human glioblastoma microvasculature

https://doi.org/10.18632/oncotarget.427

Fausto J. Rodriguez, Brent A. Orr, Keith L. Ligon,  and Charles G. Eberhart
98-106
Abstract  |  PDF  |  HTML  |  Order a Reprint

Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment

Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment

https://doi.org/10.18632/oncotarget.439

Navjotsingh Pabla,  and Zheng Dong
107-111
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2017 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC